Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Catalys Pacific
Minato-ku, Tokyo, Japancatalyspacific.com ↗
- Ownership
- Private
- Employees
- ~25
- Development stage
- Other
01
Overview
Catalys Pacific is a life sciences venture capital firm focused on creating and investing in bespoke biotech companies through transpacific partnerships, targeting areas such as hypertension, renal disease, CNS, liver disease, and oncology through its portfolio[1][2][3][4][5].
- Therapeutic areas
- EndocrinologyNephrologyGastroenterologyCardiovascularOncologyNeurology
- Modalities
- Small moleculeMonoclonal antibodyNasal spray
- Industry
- Investors
02
Partnerships
Engages in partnerships via its portfolio companies; example: D2G Oncology (for Kirilys Therapeutics)
Beyond the preview
Go deeper on Catalys Pacific.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Catalys Pacific.